This cohort study applies a heuristic, analytical procedure using z scores to data from 2 independent trials with multiple end points that examined whether ataluren is beneficial vs placebo for treating patients with Duchenne muscular dystrophy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: